Lv4
460 积分 2021-10-12 加入
Probing the Binding Interactions between Chemically Modified siRNAs and Human Argonaute 2 Using Microsecond Molecular Dynamics Simulations
1天前
待确认
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
2个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
5个月前
已完结
Multicomponent Synthesis of Imidazole-Based Ionizable Lipids for Highly Efficient and Spleen-Selective Messenger RNA Delivery
5个月前
已完结
Novel Lipid Nanoparticle (LNP) Delivery Systems Enabling the Advancement of RNA Therapeutics
5个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
6个月前
已完结
Chemical Design Strategy of Ionizable Lipids for In Vivo mRNA Delivery
7个月前
已完结
Measurement and clinical interpretation of CRISPR off-targets
8个月前
已完结
Cm-siRPred: Predicting chemically modified siRNA efficiency based on multi-view learning strategy
8个月前
已完结
皖公网安备34019202002308
